Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page footer. No other visible changes to trial details or content.
    Difference
    0.1%
    Check dated 2026-04-15T22:09:26.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A 'Results Submitted' section was added and the 'No Results Posted' note was removed.
    Difference
    0.2%
    Check dated 2026-04-01T10:20:33.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page adds the Prostate cancer tag and related topics such as MedlinePlus Genetics. The site revision is updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-25T03:13:34.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-10T15:33:06.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. This appears to be a site version update and does not affect study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-02-17T03:27:28.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Addition: Revision: v3.4.1 and deletions including the funding notice, related topics (Prostate cancer, MedlinePlus Genetics), and the older revision reference (v3.4.0). These changes do not affect the study details, endpoints, locations, or eligibility on this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-09T22:30:36.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.